Riyadh is set to host the fourth edition of the Global Medical Biotechnology Summit from September 14 to 16 under the auspicious of the Saudi Crown Prince Mohammed bin Salman, according to the Saudi Press Agency.
As one of the world’s pioneering international events in the biotechnology sector, the summit will bring together government leaders, decision-makers, as well as chief executives of major pharmaceutical companies.
Thus, the summit will offer a unique platform for experts and investors in medical biotechnology, cell and gene technologies, and artificial intelligence in the life sciences.
In line with the Saudi Vision 2030, the Global Medical Biotechnology Summit seeks to further enhance innovation and foster the Kingdom’s bioeconomy, while drawing high-quality investments in the pharmaceutical and advanced technology sectors.
Overall, the summit mirrors the Kingdom’s commitment to elevating biomedical research and launching global initiatives in public health and future technologies.
Biotechnology represents one of the key pillars of the Vision 2030, which seeks to create a vibrant and productive society and a sustainable economy.
Related Topics:
Saudi Arabia’s National Biotechnology Strategy: Leap into Future
Opening of Riyadh Global Medical Biotechnology Summit
SFDA Approves Qfitlia for Treatment of Hemophilia A and B
